HROW

Conviction 61HealthcareScan · Thu, Jun 25, 2026

HROW$41.50-2.78%

ResistanceSupportVol 14Insider buy

Vol MA14 875.72K

Mar 26Apr 14May 1May 19Jun 8Jun 25

HARROW, INC.PHARMACEUTICAL PREPARATIONSwww.harrow.com ↗

Price41.50

Change-2.78%

Gap+0.57%

Rel volume1.06×

Avg volume813.21K

Avg $ vol30.82M

SMA 2037.40

SMA 5037.09

SMA 20041.28

Price vs 50+11.89%

Price vs 200+0.51%

MA stackmixed

50/200 cross—

Supertrendup · 36.98

RSI (14)64

MACD hist0.74

MACD cross—

Stoch %K / %D74 / 82

ADX (14)30

+DI / −DI32 / 14

RSI divergence—

MACD divergence—

ATR %+4.97%

ADR %5.42%

52w high54.80

52w low29.03

From 52w high-24.28%

Above 52w low+42.94%

New 52w highNo

SqueezeOff

Bollinger width39.36%

%B0.78

Donchian pos75.06%

Donchian high44.50

Donchian low32.45

AVWAP (52w high)38.91

vs AVWAP high+6.65%

AVWAP (52w low)35.50

vs AVWAP low+16.88%

OBV trendFlat

Chaikin MF (20)-0.11

Today vs 20d1.06×

Avg vol (14d)875.72K

Avg vol (20d)813.21K

Avg $ vol (20d)30.82M

Market cap1.55B

RS 3m (vs SPY)+8.99%

RS 6m (vs SPY)-15.75%

RS line new highYes

Trend template6/8

Technical rank52.8

1 week-1.06%

1 month+21.44%

3 months+14.15%

6 months-15.97%

1 year+30.86%

YTD-16.86%

P/E-300.98

P/B53.88

P/S5.68

P/FCF35.99

EPS-0.1400

Div yield—

ROE-17.90%

ROA-1.22%

Debt/Eq10.47

Current2.48

EV/EBITDA55.06

Gross margin75.05%

Net margin-1.89%

Rev growth36.41%

EPS growth70.60%

Price target68.20

Target upside64.36%

Analyst ratingBuy

Institutional63.15%

Ent. value1.75B

Revenue44.2M

Net income-27.6M

Gross profit27.05M

Free cash flow42.98M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out37.28M

Employees373

ListedMon, Apr 30, 2007

Free float32.3M

Float %87.2%

Short interest6.69M

Days to cover8.4d

Short volume26.8%

Squeeze score66 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.63 vs −$0.43

Last surprise-46.5% miss

Setup gradeB

Conviction61 / 100

Pattern quality—

Tech rank52.8 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance43.08

Support29.28

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in HROW

All disclosures →

No recent disclosed trades by Congress in HROW. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in HROW · 8 buys

Insider	Side	Shares	Value	Traded	Filed
Graves Adrienne L Director · RSU · 2026-06-18	Grant	5.25K	—	2026-06-18	2026-06-22
SILVERNAIL LAUREN P Director · RSU · 2026-06-18	Grant	5.25K	—	2026-06-18	2026-06-22
Sternberg Perry J. Director · RSU · 2026-06-18	Grant	5.25K	—	2026-06-18	2026-06-22
SILVERNAIL LAUREN P Director · Common Stock · 2026-05-18	Buy	1K	$31K	2026-05-18	2026-05-19
Graves Adrienne L Director · Common Stock · 2026-05-18	Buy	1K	$31K	2026-05-18	2026-05-19
Shojaei Amir CHIEF SCIENTIFIC OFFICER · Restricted Stock Units · 2026-05-15	Grant	10K	$0	2026-05-15	2026-05-18
BAUM MARK L CHIEF EXECUTIVE OFFICER · Common Stock · 2026-05-14	Buy	10K	$302K	2026-05-14	2026-05-15
BOLL ANDREW R. PRESIDENT AND CFO · Common Stock · 2026-05-14	Buy	3.5K	$105K	2026-05-14	2026-05-15

SEC filings

EDGAR filings in HROW · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.